利尔化学股份有限公司 证券代码：002258 证券简称：利尔化学 利尔化学股份有限公司投资者关系活动记录表 编 号 ： 2017- 01 | --- | --- | --- | --- | |----------------|---------------------------|--------------------------------|----------------------------------------------------------| | | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | | 类别 | □媒体采访 □业绩说明会 | | | | | □ | 新闻发布会 □路演活动 | | | | □现场参观 | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 兴业证券：廖辰轩 | | | | 人员姓名 | | | | | 时间 | 2017 年 3 月 2 | 日 13:20 | | | 地点 | 公司 二楼会议室 | | | | 上市公司接待人 | 副总经理/董事会秘书：刘军 | | | | 员姓名 | 董办主任 / | 证券 ...

Group 1: Company Overview - Lier Chemical Co., Ltd. was established in 1993 and is a high-tech enterprise responding to the national military-to-civilian transition initiative, with its headquarters in Mianyang, Sichuan Province [2] - The company has over 2,000 employees and operates three production bases located in Mianyang, Nantong, and Guang'an [2] Group 2: Production Capacity and Projects - The Guang'an base is set to produce 10,000 tons/year of glyphosate, 1,000 tons/year of prometryn, and 1,000 tons/year of fluazinam, with operations expected to commence around 2019 [3] - The company is the largest producer of glyphosate in China, with a current production capacity of 5,000 tons/year at its Mianyang facility, aiming to increase total capacity to 15,000 tons/year post Guang'an base completion [3] Group 3: Market and Product Development - Since 2006, Lier has been expanding its domestic market presence, achieving significant growth in brand formulation sales and establishing a notable influence in the market [3] - The company is focused on enhancing its formulation business to complement its raw material production, having completed capital increase and restructuring for its formulation subsidiary [4] Group 4: Environmental Responsibility - Lier Chemical emphasizes safety and environmental protection, continuously investing in upgrading waste treatment facilities and optimizing production processes to reduce emissions [4] Group 5: Financial and Investment Activities - Zhongtong Investment has reduced its shareholding primarily to realize some investment returns, with ongoing communication regarding this matter [4] - The company is advancing its convertible bond refinancing process, having approved and disclosed the plan, and is currently undergoing state-owned asset approval procedures [4] Group 6: Research and Development - The company's technology center is recognized as a national enterprise technology center, focusing on the development of new products and technologies aligned with industry trends for long-term growth [4]

利尔化学股份有限公司 证券代码：002258 证券简称：利尔化学 利尔化学股份有限公司投资者关系活动记录表 编 号 ： 2017- 05 | --- | --- | --- | --- | |----------------|---------------------------|--------------------------------|----------------------------------------------------------| | | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | | 类别 | □媒体采访 □业绩说明会 | | | | | □ 新闻发布会 □路演活动 | | | | | □现场参观 | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 中金公司：文尽远 | | | | 人员姓名 | | | | | 时间 | 2017 年 8 月 25 | 日 | | | 地点 | 公司 董秘办公室 | | | | 上市公司接待人 | 副总经理/董事会秘书：刘军 | | | | 员姓名 | 董事会办公室主任 | / | 证 ...

利尔化学股份有限公司 证券代码：002258 证券简称：利尔化学 利尔化学股份有限公司投资者关系活动记录表 编 号 ： 2017- 06 | --- | --- | --- | --- | |----------------|------------------------------|--------------------------|-----------------------------------------------------------| | | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | | 类别 | □媒体采访 □业绩说明会 | | | | | □ | 新闻发布会 □路演活动 | | | | □现场参观 | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 国海证券：代鹏举 | | | | 人员姓名 | | | | | 时间 | 2017 年 8 月 29 | 日 | | | 地点 | 公司 董秘办公室 | | | | 上市公司接待人 | 副总经理/董事会秘书：刘军 | | | | 员姓名 | 董事会办公室主任 | / | 证券事 ...

Financial Performance - The company's revenue for Q3 2022 reached ¥2,664,371,729.37, representing a 137.89% increase compared to the same period last year[6] - Net profit attributable to shareholders was ¥444,515,872.22, a significant increase of 316.64% year-over-year[6] - The net profit after deducting non-recurring gains and losses was ¥433,933,144.80, up 323.43% from the previous year[6] - Total operating revenue for the current period reached ¥7,742,484,720.81, a significant increase of 80.5% compared to ¥4,279,595,345.60 in the previous period[25] - Operating profit for the current period was ¥1,993,816,319.08, up from ¥755,008,416.73, reflecting a growth of 164.5%[25] - Net profit for the current period was ¥1,672,292,899.76, compared to ¥652,921,641.50 in the previous period, marking an increase of 156.5%[25] - Basic earnings per share for the current period were ¥2.0147, compared to ¥0.8325 in the previous period, representing a growth of 142.5%[28] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥12,032,383,354.26, reflecting a growth of 17.59% compared to the end of the previous year[6] - Total liabilities increased to ¥4,701,537,848.80 from ¥4,407,632,540.61, reflecting a rise of 6.6%[21] - Total equity rose to ¥7,330,845,505.46 from ¥5,824,534,671.72, indicating an increase of 25.8%[21] - The company's fixed assets reached CNY 4,152,578,181.82, up from CNY 3,740,189,844.90, marking an increase of approximately 11.0%[18] - The total assets amounted to CNY 12,032,383,354.26, compared to CNY 10,232,167,212.33 at the beginning of the year, representing a growth of about 17.6%[18] Cash Flow - Cash flow from operating activities for the year-to-date was ¥1,764,036,388.26, showing a 246.58% increase year-over-year[6] - Operating cash inflow for the period reached CNY 7,064,165,533.39, a significant increase from CNY 3,461,802,683.50 in the previous period, representing a growth of approximately 104.6%[29] - Net cash flow from operating activities was CNY 1,764,036,388.26, compared to CNY 508,984,879.31 in the same period last year, indicating a year-over-year increase of about 247.5%[32] - Cash received from sales of goods and services was CNY 6,435,395,874.28, significantly higher than CNY 3,245,993,940.73 in the previous period, marking an increase of approximately 98.5%[29] - The ending balance of cash and cash equivalents was CNY 1,197,101,282.74, compared to CNY 895,148,797.69 at the end of the previous period, showing an increase of about 33.7%[32] Investment and Development - The company’s construction in progress increased by 69.29% to ¥158,282.78 million, indicating ongoing investment in projects[10] - Research and development expenses rose by 74.12% to ¥27,164.44 million, reflecting increased investment in innovation[10] - Research and development expenses for the current period were ¥271,644,374.07, up from ¥156,007,136.60, showing a growth of 73.9%[25] - The company has invested in new product development and technology, as indicated by the increase in intangible assets to CNY 727,304,558.20 from CNY 622,850,023.47[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 35,885, indicating a broad base of investor interest[11] - The company has a significant shareholder structure, with the largest shareholder holding 190,376,009 shares, representing a substantial portion of the total equity[14] Operational Challenges - The company experienced a production limitation due to power supply issues for over 10 days in August 2022, which negatively impacted operational performance[15] Market Strategy - The company is focused on market expansion and strategic investments to enhance its competitive position in the industry[20]

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 5,078,112,991.44, representing a 60.72% increase compared to CNY 3,159,600,234.67 in the same period last year[26]. - The net profit attributable to shareholders for the first half of 2022 was CNY 1,047,583,941.10, a 107.46% increase from CNY 504,953,337.19 in the previous year[26]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 1,050,698,840.97, up 114.61% from CNY 489,576,876.54 year-on-year[26]. - The net cash flow from operating activities reached CNY 1,296,536,529.40, marking a significant increase of 371.86% compared to CNY 274,774,118.70 in the previous year[26]. - Basic earnings per share for the first half of 2022 were CNY 1.4181, a 106.24% increase from CNY 0.6876 in the same period last year[26]. - The total assets at the end of the reporting period were CNY 11,700,632,821.03, reflecting a 14.35% increase from CNY 10,232,167,212.33 at the end of the previous year[26]. - The net assets attributable to shareholders at the end of the reporting period were CNY 5,830,605,293.02, up 17.15% from CNY 4,977,230,721.13 at the end of the previous year[26]. - The weighted average return on net assets was 19.30%, an increase of 7.34% compared to 11.96% in the previous year[26]. Market and Industry Trends - The global pesticide market size grew from $35.575 billion in 2006 to $67.629 billion in 2019, with a compound annual growth rate of 5.07%[36]. - The demand for pesticides increased significantly due to heightened concerns over food security amid geopolitical conflicts and the pandemic[36]. - The sales of pyridine herbicides reached $1.322 billion globally in 2020, with a projected growth rate of 3.4% to $1.563 billion by 2025[40]. - The global market share of major international agrochemical companies exceeds 60%, indicating a trend towards consolidation in the industry[36]. - The company is positioned to benefit from the increasing demand for green pesticides and the ongoing transformation of the pesticide industry in China[39]. Company Operations and Strategy - The company focuses on the research, production, and sales of high-efficiency, low-toxicity pesticide active ingredients, including glyphosate and chlorinated pyridine herbicides[40]. - The company has over 40 pesticide active ingredients and more than 100 formulations, catering to various agricultural needs[42]. - The company effectively organized production and improved supply chain management to meet customer demands despite challenges from the pandemic and rising raw material costs[41]. - The company has established a stable strategic partnership with top international agrochemical companies such as Corteva, BASF, and Syngenta, exporting products to over 30 countries including the USA, Brazil, and Australia[47]. - The company operates seven production bases across China, ensuring a multi-base supply guarantee for its main products[52]. - The company has a complete independent system for research and development, procurement, production, testing, and sales, ensuring effective operational management[4]. Environmental Management - The company has implemented an ISO14001 environmental management system, achieving advanced levels in environmental management within the industry[52]. - The company has increased its environmental protection investments, ensuring compliance with national standards for waste emissions, while continuing to enhance its environmental management systems[93]. - The company has implemented continuous monitoring systems across multiple discharge points to ensure compliance with environmental standards[114]. - The company reported no exceedances in pollutant discharge limits across all monitored categories[114]. - The company is committed to ongoing improvements in waste management and emissions reduction strategies[114]. - The company has established four sets of dual (multi) effect evaporation treatment devices for high-concentration wastewater, with a daily processing capacity of 800m³[121]. Financial Investments and Risks - The company has successfully completed two refinancing rounds in the past, ensuring sufficient funding for its strategic development goals[55]. - The company maintains good credit with major domestic banks, providing ample credit limits to support its business development[55]. - The company has not achieved the planned progress and expected returns for several projects, with reasons not specified in the report[68]. - The company is focusing on expanding its investment in the chemical industry, particularly in pesticide intermediates[68]. - The company has implemented measures to mitigate foreign exchange risks, including establishing internal control systems for derivative trading[81]. Corporate Governance and Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares[6]. - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 25.58% of the shares, totaling 190,376,009 shares, with an increase of 54,393,145 shares during the reporting period[187]. - The total number of ordinary shareholders at the end of the reporting period was 31,287, with significant changes in the top shareholders[187]. - The company did not engage in any repurchase transactions during the reporting period[191]. - The report indicates that there are no known related party relationships among the top shareholders, except for the connection between Sichuan Jiuyuan Investment Holding Group and Sichuan Huacai Technology Co., Ltd.[190]. Employee and Community Engagement - The company has actively participated in social responsibility initiatives, including organizing over 20 volunteer activities related to COVID-19 prevention and environmental beautification[140]. - During the reporting period, the company provided assistance to employees facing difficulties, resolving 13 specific issues through its union and charitable fund[139]. - The company has organized 15 cultural and sports activities to enhance employee engagement and cohesion[139]. - The company has established a robust employee health and safety program, including regular health check-ups and safety training sessions[139]. Safety and Compliance - The company has implemented a comprehensive safety management system, achieving 7,150 days without safety or environmental incidents at its subsidiary, Xingxing Huachuang[142]. - The company has developed a strict monitoring mechanism for safety and environmental checks, ensuring timely rectification of identified hazards[141]. - The company received a safety administrative penalty of RMB 46,000, which did not significantly impact its performance[155].

Financial Performance - The company's revenue for Q1 2022 reached ¥2,612,935,661.17, representing a 76.32% increase compared to ¥1,481,933,864.23 in the same period last year[3] - Net profit attributable to shareholders was ¥534,331,688.15, a significant increase of 142.02% from ¥220,781,407.74 year-on-year[3] - Basic earnings per share increased to ¥1.0143, reflecting a growth of 140.93% compared to ¥0.4210 in the same period last year[3] - Net profit for the current period was ¥591,086,437.05, compared to ¥245,143,801.01 in the previous period, reflecting an increase of approximately 141.5%[29] - The company reported a gross profit of ¥693,274,955.63, which is a significant increase from the previous period's gross profit of ¥278,246,058.82, representing an increase of approximately 149.5%[26] - The company’s total profit for the current period was ¥697,575,992.54, compared to ¥283,484,475.67 in the previous period, reflecting an increase of about 146.5%[26] Cash Flow - The net cash flow from operating activities was ¥204,771,003.87, up 170.19% from ¥75,788,109.36 in the previous year[3] - Cash inflow from operating activities totaled ¥1,771,206,934.98, compared to ¥1,077,868,134.56 in the previous period, showing an increase of approximately 64.4%[30] - Total cash outflow from operating activities amounted to $1,566,435,931.11, compared to $1,002,080,025.20 last year[33] - Cash inflow from investment activities was $10,223,931.69, significantly up from $2,674,432.02 in the prior year[33] - Net cash flow from financing activities improved to $106,501,060.07 from -$21,440,015.57 in the previous period[33] Assets and Liabilities - Total assets at the end of the reporting period were ¥11,203,104,813.36, a 9.49% increase from ¥10,232,167,212.33 at the end of the previous year[3] - Total current assets increased to CNY 5,356,798,646.92 from CNY 4,679,363,321.75, reflecting a growth of approximately 14.5%[14] - Total liabilities increased to CNY 4,991,961,194.45 from CNY 4,407,632,540.61, representing a rise of approximately 13.3%[22] - The company's equity attributable to shareholders rose to CNY 5,273,726,545.44 from CNY 4,977,230,721.13, an increase of about 6%[22] Operating Costs and Expenses - The company’s operating costs increased by 62.07% to ¥171,991.34, attributed to rising sales and costs of certain products[9] - Total operating costs amounted to ¥1,919,660,705.54, up from ¥1,203,687,805.41, indicating a rise of about 59.5%[26] - Research and development expenses for the current period were ¥62,723,198.01, up from ¥48,709,321.12, indicating an increase of about 28.8%[26] Investments and Other Income - The company reported a significant increase in investment income, which rose to ¥622,901.91 from ¥60,815.94, indicating a growth of approximately 925.5%[26] - The company reported a 51.57% increase in accounts receivable, reaching ¥192,106.41, due to business growth[6] - The company’s other non-current assets increased by 76.43% to ¥25,438.17, mainly due to prepayments for new project equipment[6] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to sustain growth[28]

Financial Performance - The company reported a total revenue of 5.268 billion CNY for the year 2021, representing a year-on-year increase of 20%[6]. - The net profit attributable to shareholders reached 1.052 billion CNY, an increase of 25% compared to the previous year[6]. - The company's operating revenue for 2021 was ¥6,494,251,256.27, representing a 30.70% increase compared to ¥4,968,747,823.74 in 2020[33]. - The net profit attributable to shareholders for 2021 was ¥1,072,386,632.75, a 75.17% increase from ¥612,208,873.95 in 2020[33]. - The net profit after deducting non-recurring gains and losses for 2021 was ¥1,063,471,931.26, up 82.23% from ¥583,603,687.46 in 2020[33]. - The net cash flow from operating activities for 2021 was ¥1,317,229,894.38, an increase of 46.52% compared to ¥899,001,364.24 in 2020[33]. - The basic earnings per share for 2021 was ¥2.0416, a 74.87% increase from ¥1.1675 in 2020[33]. - The diluted earnings per share for 2021 was ¥1.9469, up 72.77% from ¥1.1269 in 2020[33]. - The total assets at the end of 2021 were ¥10,232,167,212.33, a 20.90% increase from ¥8,463,205,858.12 at the end of 2020[33]. - The net assets attributable to shareholders at the end of 2021 were ¥4,977,230,721.13, a 25.29% increase from ¥3,972,556,171.06 at the end of 2020[33]. Market Expansion and Strategy - The company is focusing on expanding its market presence, particularly in the agricultural chemicals sector, aiming for a 15% growth in market share by 2023[6]. - The company is exploring potential mergers and acquisitions to enhance its product portfolio and market reach, with a budget of 500 million CNY earmarked for this purpose[6]. - The company has established long-term strategic partnerships with top international agrochemical firms such as Corteva, BASF, and Syngenta, ensuring a stable customer base and good reputation[51]. - The company is actively pursuing environmental compliance projects, including a new pesticide pilot research project approved in 2021[69]. - The company plans to enhance its product development capabilities and expand its market presence through strategic alliances and technological advancements[92]. - The company aims to achieve a market expansion strategy targeting new geographical regions to increase its customer base[194]. Research and Development - The company has allocated 200 million CNY for research and development in 2022, targeting advancements in eco-friendly chemical solutions[6]. - New product development efforts have led to the introduction of 10 innovative chemical products in 2021, contributing to a 30% increase in sales from new products[6]. - The total R&D investment for 2021 was ¥262,736,823.59, a 32.04% increase from ¥198,978,245.35 in 2020[109]. - Research and development expenses rose by 31.37% to ¥247,090,973.21 in 2021 from ¥188,091,142.28 in 2020[108]. - The company is focusing on new product development, including L-草铵膦 and new flame retardants, to create new profit growth points[109]. Environmental and Regulatory Compliance - The company is actively pursuing environmental compliance projects, including a new pesticide pilot research project approved in 2021[69]. - Environmental regulations are becoming stricter, requiring increased investment in environmental protection measures[163]. - The company has a total of 8 environmental permits and licenses, with several expiring in 2023 and 2024, necessitating timely renewals[72]. Supply Chain and Production - The company follows a comprehensive procurement system for raw materials and production equipment, ensuring efficient supply chain management[63]. - The production process for glyphosate involves multiple chemical synthesis steps, ensuring high-quality output[60]. - The production capacity for the main product, raw materials, is designed at 48,550 tons/year with a utilization rate of 74.89%[66]. - The production capacity for formulations is designed at 43,820 tons/year with a high utilization rate of 98.12%[66]. - The energy procurement price constitutes over 30% of total production costs, indicating a significant cost factor for the company[66]. Financial Management and Governance - The company has established an independent audit department with 4 dedicated auditors to oversee internal controls, project management, and financial status[182]. - The company maintains complete independence from its controlling shareholders in terms of business operations, personnel, assets, and financial management[183]. - The company has a well-established organizational structure that operates independently without subordination to controlling shareholders[183]. - The company emphasizes timely and accurate information disclosure, maintaining open communication with investors and regulatory bodies[179]. - The company has established a comprehensive governance structure in compliance with relevant laws and regulations, ensuring effective decision-making and communication with investors[172]. Risk Factors - The company faces risks related to raw material price fluctuations and environmental regulations, which may impact future profitability[6]. - The company anticipates risks from market competition and raw material price fluctuations, which could impact sales and profitability[163]. - The company has implemented measures to mitigate risks associated with foreign exchange fluctuations and customer payment delays[135].

Financial Performance - The company's revenue for Q3 2021 was ¥1,119,995,110.93, representing a year-on-year increase of 10.78%[3] - The net profit attributable to shareholders for Q3 2021 was ¥106,691,101.09, a decrease of 33.87% compared to the same period last year[3] - The net profit after deducting non-recurring gains and losses was ¥102,479,696.49, down 34.20% year-on-year[3] - Total operating revenue for the current period reached ¥4,279,595,345.60, a 27.3% increase from ¥3,359,919,009.26 in the previous period[19] - Net profit for the current period was ¥652,921,641.50, representing a 44.7% increase compared to ¥450,875,901.92 in the previous period[22] - Earnings per share (basic) rose to ¥1.1655, up from ¥0.7947 in the previous period[24] - The company reported a total comprehensive income of ¥652,921,641.50 for the current period, compared to ¥450,875,901.92 in the previous period[25] Assets and Liabilities - The total assets at the end of Q3 2021 amounted to ¥8,870,268,307.98, an increase of 4.81% from the end of the previous year[3] - The equity attributable to shareholders increased to ¥4,516,403,597.39, reflecting a growth of 13.69% compared to the end of last year[3] - The company's total current assets as of September 30, 2021, amounted to 3,522,110,380.21 RMB, a slight decrease from 3,544,112,438.70 RMB at the end of 2020[12] - Total liabilities amounted to ¥3,564,995,469.40, a decrease from ¥3,753,875,777.30 in the previous period[18] - Current liabilities decreased to 1,931,342,998.00 RMB from 2,558,803,818.92 RMB year-over-year[15] Cash Flow - The cash flow from operating activities for the year-to-date period was ¥508,984,879.31, up 24.64% year-on-year[3] - Cash flow from operating activities totaled ¥3,461,802,683.50, compared to ¥2,762,824,441.47 in the previous period, indicating a significant increase[26] - The net cash flow from operating activities was 508,984,879.31, an increase from 408,353,749.52 in the previous period, reflecting a growth of approximately 24%[29] - The total cash outflow from investing activities was 558,792,237.82, compared to 677,986,051.10 in the previous period, indicating a decrease of about 17.6%[29] - The net cash flow from financing activities was -197,965,546.32, a significant decline from a positive cash flow of 949,962.73 in the previous period[29] - The total cash and cash equivalents at the end of the period amounted to 895,148,797.69, up from 580,534,105.22 in the previous period, representing an increase of approximately 54.3%[29] Shareholder Information - Total number of common shareholders at the end of the reporting period was 28,260[9] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 25.81% of shares, totaling 135,982,864 shares[9] Operational Costs and Expenses - The company experienced a 30.83% increase in operating costs, amounting to ¥308,118.04 million, primarily due to increased revenue and transportation costs[6] - Total operating costs increased to ¥3,556,619,781.07, up 24.5% from ¥2,856,416,753.45 in the previous period[19] - The company paid 494,701,340.22 in employee-related cash payments, which is an increase from 387,579,805.72 in the previous period, reflecting a rise of about 27.5%[29] - The cash paid for taxes was 140,311,900.30, compared to 87,568,562.95 in the previous period, showing an increase of approximately 60%[29] - The cash paid for dividends and interest was 150,523,714.06, which increased from 52,969,104.06 in the previous period, reflecting a rise of approximately 184%[29] Investment and R&D - The company reported a significant increase in prepayments, which rose by 240.76% to ¥22,672.61 million due to increased operational prepayments[6] - Research and development expenses remained stable at approximately ¥156 million, indicating a focus on innovation[22] - The company has shown a strong performance in net investment income, with a reported income of ¥333,555.16, compared to ¥1,140,010.63 in the previous period[22]

Financial Performance - The company's operating revenue for the first half of 2021 was ¥3,159,600,234.67, representing a 34.51% increase compared to ¥2,348,895,340.91 in the same period last year[27]. - The net profit attributable to shareholders for the first half of 2021 was ¥504,953,337.19, a significant increase of 97.70% from ¥255,408,964.36 in the previous year[27]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥489,576,876.54, up 103.24% from ¥240,884,166.31 year-on-year[27]. - The basic earnings per share for the first half of 2021 was ¥0.9630, compared to ¥0.4871 in the same period last year, reflecting a 97.70% increase[27]. - The diluted earnings per share was ¥0.9165, an increase of 92.87% from ¥0.4752 in the previous year[27]. - The weighted average return on equity was 11.96%, up from 7.33% in the same period last year, an increase of 4.63 percentage points[27]. - Total assets at the end of the reporting period were ¥8,599,718,122.24, a 1.61% increase from ¥8,463,205,858.12 at the end of the previous year[27]. - The net assets attributable to shareholders at the end of the reporting period were ¥4,388,340,495.94, reflecting a 10.47% increase from ¥3,972,556,171.06 at the end of the previous year[27]. - The net cash flow from operating activities was ¥274,774,118.70, which is an 8.73% decrease compared to ¥301,064,832.18 in the same period last year[27]. Market and Product Insights - The global crop protection market was valued at $62.036 billion in 2020, with a year-on-year growth of 2.7%[37]. - The sales of herbicides accounted for 44.2% of the global crop protection market, with a sales value of $27.407 billion in 2020, growing by 2.9%[37]. - The company’s main product, glyphosate, is one of the top three non-selective herbicides globally, with increasing demand due to the promotion of transgenic technology[41]. - The company’s pyridine herbicides saw sales growth to $1.322 billion in 2020, capturing 4.4% of the global herbicide market[41]. - The company has seen an increase in market demand and sales prices for its main products during the reporting period[51]. Research and Development - The company’s research and development focus includes high-efficiency, low-toxicity, and low-residue pesticides[41]. - The company has a strong R&D team with advanced facilities, focusing on the innovation of pesticide products and processes[52]. - The company has successfully mastered the key technology for the industrialization of cyano-pyridine chlorination, becoming the second company globally to do so after Dow AgroSciences[52]. Environmental Management - The company has implemented a comprehensive environmental management system, achieving ISO 14001 certification and maintaining advanced industry standards[53]. - The company has invested significantly in environmental protection facilities, with increasing expenditures on waste treatment to comply with stricter national standards[95]. - The company has achieved compliance with national pollution discharge standards, with total wastewater discharge recorded at 27.32 tons against a permitted limit of 218.86 tons per annum[108]. - The company has maintained a zero incident record for major safety accidents during the reporting period, although risks remain as production scales up[95]. - The company has enhanced its control over non-organized VOC emissions, increasing monitoring points and installing automatic monitoring devices[121]. Strategic Partnerships and Market Position - The company has established a stable strategic partnership with top international agrochemical companies, exporting products to over 30 countries including the USA, Brazil, and Australia[51]. - The company operates under a "sales-driven production" principle, aligning production plans with market demand[46]. - The company has developed a robust procurement system to optimize the purchasing and storage of raw materials[46]. Challenges and Risks - The company faced challenges such as rising raw material prices and logistics issues but ensured stable production and supply[41]. - The company faces significant competition risk in the pesticide industry, which may impact sales and profitability, prompting a focus on product optimization and new product development[93]. - Raw material costs constitute a large portion of operating costs, and fluctuations in supply and prices could significantly affect gross margins and profitability[94]. Corporate Governance and Compliance - The company’s half-year financial report was not audited, indicating a lack of external verification for the reported figures[143]. - The company reported no significant litigation or arbitration matters during the reporting period[146]. - The company has complied with all regulatory requirements regarding share issuance and changes in shareholding[183]. Employee Engagement and Community Support - In the first half of 2021, the company organized 12 cultural and sports activities, with over 2,500 employee participations, enhancing employee skills and work quality[136]. - The company participated in targeted poverty alleviation efforts, purchasing local agricultural products worth around CNY 400,000 to support local agricultural development[136]. - The company donated a total of CNY 200,000 to help impoverished students in Mianyang City and Beichuan County[136].